Chat IA
Loading data for MOBI — first visit, this takes a few seconds.

Mobia Medical, Inc.

MOBI · NasdaqGS · USD

10.01 -0.24 (-2.34%)

À la clôture : Sep 11, 2026, 8:00 PM

Volume
133K

Mobia Medical, Inc. (MOBI) : cours, analyse et données

Valeur intrinsèque

Chargement de la valeur intrinsèque…

Prévisions des analystes

Prévisions boursières →

Prévisions des analystes indisponibles

Objectif à 12 mois · n/a analystes

Consensus des analystes : n/a

Intervalle:1D
Chargement des bougies et signaux…

Performance financière

Voir les finances →

Chargement...

Derniers résultats

SignaléÉcart estiméChangement d’une année sur l’autre
Chiffre d’affaires$13.51Mn/an/a
EPS-$1,10-$0,30n/a

Prochains résultats

pendant les heures de marché.

Estimation · Passer à l’offre supérieure →

Voir les résultats détaillés →

Métriques

Cours acheteur
7.42
Résultat net (ttm)
-64.1M
n/a
-1.93
n/a
-4.54
P/B (ttm)
1.93
P/S (ttm)
7.36
Date des résultats
Nov 9, 2026
Cours vendeur
12.94
Volume
132,552
Volume moy. (20D)
148,759
Ouverture
10.36
Clôture précédente
10.25
Fourchette du jour
10.01 - 10.48
Intervalle de 52 semaines
10.01 - 15.29
Date ex-dividende
n/a

À propos de Mobia Medical, Inc.

Voir le profil →
Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions. Its main product, the Vivistim System, is an FDA-approved implantable device designed to aid in the rehabilitation of upper limb motor function in post-stroke patients. The paired VNS platform is used to help patients relearn movements and improve motor deficits, and it is being developed for additional chronic neurologic conditions such as tinnitus. The company supports healthcare professionals, patients, and caregivers with information and resources related to its offerings. The company serves healthcare professionals and organizations involved in stroke rehabilitation and chronic neurological conditions, as well as patients and caregivers within the healthcare sector. The company was founded in 2007 and is based in Austin, Texas. Medical Devices · Healthcare

Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions. Its main product, the Vivistim System, is an FDA-approved implantable device designed to aid in the rehabilitation of upper limb motor function in post-stroke patients. The paired VNS platform is used to help patients relearn movements and improve motor deficits, and it is being developed for additional chronic neurologic conditions such as tinnitus. The company supports healthcare professionals, patients, and caregivers with information and resources related to its offerings. The company serves healthcare professionals and organizations involved in stroke rehabilitation and chronic neurological conditions, as well as patients and caregivers within the healthcare sector. The company was founded in 2007 and is based in Austin, Texas.

Industrie Medical Devices
Secteur Healthcare
Date d’introduction May 8, 2026
Employés 167
Bourse NasdaqGS
Symbole boursier MOBI